.jpg)
Motive Partners and CC Capital Reach Agreement to Sell Wilshire to Marsh
Transaction reflects realization of Motive’s value creation transformation of Wilshire into a scaled, technology-enabled investment solutions, data and analytics platform.
Latest stories

Motive Partners Appoints Umesh Subramanian as Partner, Joins Ranks of Firm’s Other High-Caliber Talent, Bringing One of Wall Street’s Most Influential CTOs Into Private Markets
Citadel Chief Technology Officer and former Goldman Sachs Partner joins Motive’s Executive Leadership Team and Investment Committee in a move signaling a new phase of AI-driven transformation across financial services

VeCollal® / Corpowell secures Investment from Seventure Partners (Health for Life Capital™) to Accelerate Expansion of Plant-Based Collagen Alternative
- VeCollal® technology, based on biomimetic science, sets a new standard for sustainability and results in the ingestible beauty and nutraceuticals sector. - Clinical Breakthrough with -20.1% Reduction in Visible Cellulite to be presented at Fi Europe
Contact us
.jpg)



.jpg)


.jpg)

